Original research
by
Kurz, M. et al
Release Date
2021
Geography
Canada
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
We aimed to estimate the impact of policy changes and the announcement of the opioid overdose-related public health emergency on the use of OAT for incarcerated individuals with opioid use disorder.
Findings/Key points
Following an expansion of healthcare insurance coverage to include buprenorphine/naloxone, receipt of opioid agonist treatment (OAT) within correctional facilities in British Columbia, Canada increased, largely driven by an increase in buprenorphine/naloxone prescriptions among individuals without recent OAT experience.
Design/methods
Interrupted time series analysis, n=9220. Events of interest included the expansion of buprenorphine/naloxone into provincial health care insurance coverage in October 2015 and the public health emergency declared in April 2016.
Keywords
Policy/Regulatory
Legal system/law enforcement
Substitution/OAT
